Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
What is the price prediction for Curaleaf stock? ›
CURLF Stock 12 Month Forecast
Based on 5 Wall Street analysts offering 12 month price targets for Curaleaf Holdings in the last 3 months. The average price target is $6.05 with a high forecast of $8.10 and a low forecast of $3.75. The average price target represents a 113.03% change from the last price of $2.84.
The forecasts for Cresco Labs Inc. (CRLBF) range from a low of $2.5 to a high of $14.32. The average price target represents a increase of $176.57 from the last closing price of $1.75.
Is curlf a good buy? ›Average Brokerage Rating
(CURLF) currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.)
Based on analyst ratings, Curaleaf Holdings's 12-month average price target is C$8.21. Curaleaf Holdings has 107.37% upside potential, based on the analysts' average price target. Curaleaf Holdings has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
Is Curaleaf a growing company? ›Boris Jordan, Executive Chairman of Curaleaf, stated, "Consistent with our expectations, first quarter revenue grew 2% to $339 million, and we achieved a 48% adjusted gross margin. Adjusted EBITDA margin(1) was $77 million or 23% of sales, expanding 40bps from last year.
What is the earnings forecast for curlf? ›What is CURLF EPS forecast? CURLF EPS forecast for the fiscal quarter 2024 (Q3) is -$0.06.
How many shares of Curaleaf are there? ›Institutional Ownership and Shareholders
Curaleaf Holdings, Inc. (US:CURLF) has 19 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,252,524 shares.
P/E ratio as of September 2024 (TTM): -4.69
According to Curaleaf's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.69273. At the end of 2022 the company had a P/E ratio of -8.34.
Futures are derivatives, which are financial contracts whose value comes from changes in the price of the underlying asset. Stock market futures trading obligates the buyer to purchase or the seller to sell a stock or set of stocks at a predetermined future date and price.
Is Curaleaf in debt? ›Total debt on the balance sheet as of June 2024 : $0.85 B.
What company did Curaleaf buy? ›
(TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the closing of its acquisition of Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international ...
Who owns Curlf? ›The ownership structure of Curaleaf Holdings (CURLF) stock is a mix of institutional, retail and individual investors. Approximately 9.98% of the company's stock is owned by Institutional Investors, 33.22% is owned by Insiders and 56.80% is owned by Public Companies and Individual Investors.
What is the long term forecast for Curaleaf stock? ›The average one-year price target for Curaleaf Holdings, Inc. is $7.97. The forecasts range from a low of $5.22 to a high of $18.31. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.
Is Curaleaf a good brand? ›With its New York-based headquarters, Curaleaf has established itself as the nation's largest retail marijuana brand, known for its premium, safe, and consistently high-quality cannabis products.
What are the best deals at Curaleaf? ›- 30% Off WYLD!
- 50% Off JAMS Gummies!
- Airo Pro: BOGO for $0.01!
- 10 for $50 1g Pre-Rolls & Flower!
- 2 for $30 1g Infused Pre-Rolls!
- Gummies & Edibles: 2 for $30!
- 2 for $40: 1g Cured Concentrates!
- 2 for $60: 1g Live Resin Concentrates!
What are analysts forecasts for Progressive stock? The 99 analysts offering price forecasts for Progressive have a median target of 172.90, with a high estimate of 293.00 and a low estimate of 103.00. The median estimate represents a 144.08 difference from the last price of 249.12.
What is the price prediction for Flora Growth stock in 2025? ›On average, Wall Street analysts predict that Flora Growth's share price could reach $6.50 by May 16, 2025. The average Flora Growth stock price prediction forecasts a potential upside of 577.08% from the current FLGC share price of $0.96.
Is Bloom stock a good buy? ›Bloom Energy has a consensus rating of Moderate Buy which is based on 5 buy ratings, 8 hold ratings and 1 sell ratings. What is Bloom Energy's price target? The average price target for Bloom Energy is $15.17. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
Who is the majority shareholder of Curaleaf? ›Who owns the most shares of Curaleaf Holdings (CURLF)? Andrey Sergeevich Blokh owns the most shares of Curaleaf Holdings (CURLF).